| Report ID | Date of report | Patient age | Patient gender |
| 108079 | May, 2, 2006 | 17 | Female |
List of drugs the patient takes:
| Drug | Ingredient(s) |
Accutane | isotretinoin |
| Name |
Animal Bite |
Asthma |
Back Pain |
Bronchitis |
Bronchopneumonia |
Chronic Sinusitis |
Eye Disorder |
Hyperkeratosis |
Inflammatory Bowel Disease |
Irritable Bowel Syndrome |
Melanocytic Naevus |
Menstruation Irregular |
Myalgia |
Myofascial Pain Syndrome |
Nail Infection |
Pityriasis Lichenoides Et Varioliformis Acuta |
Respiratory Tract Infection |
Sinusitis |
Upper Respiratory Tract Infection |
Urinary Tract Infection |
Xerosis |
Results from eHealthMe : 26863 report(s)
Comparison with the patient:
| Name | Count (% of total reports) |
Animal Bite | 10 (0.04%) |
Asthma | 277 (1.03%) |
Back Pain | 2120 (7.89%) |
Bronchitis | 398 (1.48%) |
Bronchopneumonia | 7 (0.03%) |
Chronic Sinusitis | 34 (0.13%) |
Eye Disorder | 63 (0.23%) |
Hyperkeratosis | 68 (0.25%) |
Inflammatory Bowel Disease | 5922 (22.05%) |
Irritable Bowel Syndrome | 2168 (8.07%) |
Melanocytic Naevus | 235 (0.87%) |
Menstruation Irregular | 221 (0.82%) |
Myalgia | 1161 (4.32%) |
Myofascial Pain Syndrome | 42 (0.16%) |
Nail Infection | 16 (0.06%) |
Pityriasis Lichenoides Et Varioliformis Acuta | 5 (0.02%) |
Respiratory Tract Infection | 43 (0.16%) |
Sinusitis | 607 (2.26%) |
Upper Respiratory Tract Infection | 437 (1.63%) |
Urinary Tract Infection | 369 (1.37%) |
Xerosis | 112 (0.42%) |
Top 3 (total: 1913. Click here to see more) co-used drugs - potential interacting drugs:
| Name | Count (% of total co-drugs) |
Amnesteem | 1341 (1.64%) |
Ortho Tri-cyclen | 1013 (1.24%) |
Claravis | 920 (1.13%) |
Death reported: 180 (0.67% of total reports)
| Name | Count (% of total reports) |
Inflammatory Bowel Disease | 5922 (22.05%) |
Depression | 4633 (17.25%) |
Colitis Ulcerative | 4513 (16.80%) |
-----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
Recent drug risk analysis reports:
